@joshua/obstetric-emergencies
Obstetric emergencies and drugs in pregnancy
Author-made · not reviewedObstetricsCC BY 4.0
Written by the BenchClub team with AI help. Answers follow public guidelines and textbooks; not yet reviewed by a practising physician.
v130 questionsUpdated Nov 18, 2026
- OB-001Multiple choiceObstetricsBasic
A 26-year-old primigravida at 36 2/7 weeks presents with a 1-day headache. In the waiting room she loses consciousness and has a generalized tonic-clonic seizure lasting about 1 minute that stops spontaneously. BP is 172/114 mm Hg, urine protein 3+, and the fetal heart rate 150 bpm. She has been placed in the left lateral position, the airway is protected, and oxygen is running. For seizure management, the preferred next pharmacologic step is:
- ADiazepam 10 mg slow IV push, reassessing the need for other agents once the seizure is controlled
- BPhenytoin IV loading dose plus oral labetalol for blood pressure
- CMagnesium sulfate 4–6 g IV over 20–30 minutes, then 1–2 g/h continuous infusion
- DMannitol 20% 250 mL rapid IV infusion to lower intracranial pressure
- EImmediate cesarean delivery under general anesthesia, with anticonvulsants given afterward
Show answer
Answer C
Source ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (2020)
- OB-002Multiple choiceObstetricsIntermediate
A 32-year-old primigravida at 35 weeks has preeclampsia with severe features. Serum creatinine is 2.1 mg/dL, urine output has totaled 30 mL over the past 2 hours, patellar reflexes are present, and respiratory rate is 18/min. Magnesium sulfate is planned for seizure prophylaxis. The most appropriate regimen is:
- AGive the usual 4–6 g loading dose; reduce or hold the maintenance infusion and titrate to serum magnesium, reflexes, respirations, and urine output
- BOmit the loading dose and start maintenance at 1 g/h
- CHalve the loading dose to 2 g, then maintain at 0.5 g/h
- DGive the usual loading and maintenance doses; renal function does not affect magnesium dosing
- EMagnesium is contraindicated in renal insufficiency; use diazepam for seizure prophylaxis instead
Show answer
Answer A
Source ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (2020)
- OB-003Multiple choiceObstetricsBasic
A 34-year-old woman with a 5-year history of chronic hypertension takes enalapril 10 mg daily, with BP around 135/85 mm Hg. She is now 7 weeks pregnant with a viable intrauterine pregnancy. Office BP is 148/96 mm Hg; urine protein is negative and there is no evidence of end-organ damage. Regarding her antihypertensive therapy, the most appropriate management is:
- AFirst-trimester ACE inhibitor risk is low; continue enalapril until 12 weeks, then switch
- BSwitch enalapril to losartan to avoid cough while preserving renal protection
- CStop enalapril now and switch to labetalol or extended-release nifedipine, continuing treatment to a goal below 140/90 mm Hg
- DStop all antihypertensives; drug therapy is not needed until BP reaches 160/110 mm Hg
- ERecommend termination because of first-trimester ACE inhibitor exposure
Show answer
Answer C
Source ACOG Practice Advisory: Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study (2022); Tita ATN et al., N Engl J Med 2022 (CHAP trial)
- OB-004Short answerObstetricsAdvanced
A 29-year-old primigravida at 31 3/7 weeks presents with 6 hours of right upper quadrant pain and nausea. BP is 154/98 mm Hg and urine protein 2+. Platelets 58,000/μL, AST 236 U/L, ALT 198 U/L, LDH 910 U/L, total bilirubin 1.9 mg/dL; the peripheral smear shows schistocytes. The NST is reactive and the ultrasound estimated fetal weight is 1600 g. Give the diagnosis and a management plan, including timing of delivery.
Rubric
- +2Diagnoses HELLP syndrome and cites hemolysis, elevated liver enzymes, and thrombocytopenia
- +1Gives magnesium sulfate (seizure prophylaxis and/or fetal neuroprotection)
- +1States the severe-range threshold (systolic ≥160 or diastolic ≥110 mm Hg) and that her current BP is below it, or names first-line agents for use if severe-range BP develops (giving IV antihypertensives now earns no credit)
- +2Gives antenatal corticosteroids (betamethasone 12 mg IM every 24 hours × 2, or dexamethasone 6 mg IM every 12 hours × 4)
- +3Delivers after completing the steroid course (about 24–48 hours) if stable and immediately if deteriorating; does not continue expectant management to 34 weeks (prompt delivery after stabilization with steroids started also earns full credit)
- +1Recognizes the risk of subcapsular hematoma or rupture and obtains or considers liver imaging given her RUQ pain
- +1Gives a platelet threshold: transfusion before cesarean below about 40,000–50,000/μL, or neuraxial at ≥70,000/μL with a recent stable count (individualized at 50,000–70,000/μL)
- -3(applied once) Recommends expectant management to 34 weeks or term, or uses high-dose corticosteroids to treat HELLP in place of delivery
Show answer
Reference answer Diagnosis: HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), a severe feature of preeclampsia. Management: (1) Care in a tertiary center with maternal-fetal medicine, anesthesia, neonatology, and critical care. (2) Magnesium sulfate 4–6 g IV over 20–30 minutes, then 1–2 g/h, for seizure prophylaxis (also fetal neuroprotection before 32 weeks). (3) Treat severe-range BP (systolic ≥160 or diastolic ≥110 mm Hg, confirmed within 15 minutes) within 30–60 minutes with IV labetalol, IV hydralazine, or oral immediate-release nifedipine; her current BP is below the severe range, so monitor closely. (4) Antenatal corticosteroids (betamethasone 12 mg IM every 24 hours × 2) for fetal lung maturity. (5) If mother and fetus are stable, delivery may be delayed 24–48 hours to complete the steroid course; expectant management to 34 weeks is not recommended. Deliver immediately for maternal deterioration, nonreassuring fetal status, DIC, or suspected hepatic hematoma or rupture. (6) Her RUQ pain raises concern for subcapsular hematoma: obtain or strongly consider liver imaging (ultrasound, CT, or MRI); new shoulder pain, hypotension, or shock suggests rupture, a surgical emergency. (7) Check coagulation studies, fibrinogen, glucose, and creatinine; the differential includes acute fatty liver of pregnancy and TTP/HUS. Trend platelets; transfuse before cesarean if below about 40,000–50,000/μL (always if bleeding or below 20,000/μL). At 58,000/μL she is in the 50,000–70,000/μL range where neuraxial anesthesia is an individualized decision; it is reasonable at ≥70,000/μL with a stable count from within about 6 hours and no coagulopathy. Involve anesthesia early and prepare for general anesthesia. HELLP alone is not an indication for cesarean, although at 31 weeks with an unfavorable cervix cesarean is often chosen.
Source ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (2020); ACOG Committee Opinion No. 767 (2019); ACOG Committee Opinion No. 455: Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection; ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy (2019); SOAP Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia (2021)
- OB-005Short answerObstetricsIntermediate
A 35-year-old primigravida at 35 1/7 weeks has a BP of 174/116 mm Hg at a prenatal visit and 170/112 mm Hg 15 minutes later, with persistent headache and blurred vision. She has no history of hypertension; urine protein is 2+, and platelet count and liver and renal function are pending. Describe management in the first hour (drugs, doses, BP target) and the delivery plan.
Rubric
- +2Recognizes a hypertensive emergency and starts antihypertensive treatment within 30–60 minutes, in clinic or on arrival in labor and delivery (transfer alone without treatment earns 0)
- +2Gives the correct starting dose and repeat or escalation scheme for any first-line agent (IV labetalol, oral immediate-release nifedipine, IV hydralazine); if several regimens are given, all stated doses must be correct; rescue doses are not required but, if stated, must match CO 767
- +2Gives magnesium loading and maintenance doses with monitoring of reflexes, respirations, and urine output
- +1States a target of about 140–150/90–100 mm Hg (or below the severe range but not normotensive) and warns against lowering BP too far or too fast
- +1Orders at least platelets, liver enzymes, creatinine, and continuous fetal monitoring (all four required)
- +2Recommends delivery at ≥34 weeks after maternal stabilization and does not delay delivery to complete corticosteroids (giving steroids without delaying delivery is acceptable)
- -3(applied once; minimum total 0) Gives sublingual nifedipine or an ACE inhibitor/ARB, or plans expectant management or delays delivery beyond maternal stabilization (including to complete corticosteroids)
Show answer
Reference answer This is acute-onset severe hypertension (systolic ≥160 or diastolic ≥110 mm Hg persisting ≥15 minutes) with headache and visual symptoms: preeclampsia with severe features, an obstetric emergency. (1) Arrange immediate transfer to labor and delivery with IV access; if IV access is not yet available, start oral immediate-release nifedipine in clinic. Start treatment within 30–60 minutes with any first-line regimen: IV labetalol 20 mg, then 40 mg, then 80 mg at 10-minute intervals, switching to IV hydralazine 10 mg if still severe after 80 mg; or oral immediate-release nifedipine 10 mg, then 20 mg after 20 minutes, then 20 mg after another 20 minutes, switching to IV labetalol 80 mg over 2 minutes with emergency consultation if still uncontrolled; or IV hydralazine 5–10 mg, then 10 mg after 20 minutes if needed, switching to IV labetalol 20 mg if still severe; consult maternal-fetal medicine or critical care if refractory. Labetalol is relatively contraindicated in asthma, heart block, or bradycardia. Do not give nifedipine sublingually. (2) Target about 140–150/90–100 mm Hg; avoid precipitous or excessive lowering, since the goal is not normotension. (3) Magnesium sulfate 4–6 g IV over 20–30 minutes, then 1–2 g/h; monitor reflexes, respirations, and urine output; reduce or hold the maintenance infusion if creatinine is elevated or urine output is below 30 mL/h, check serum magnesium with renal impairment or suspected toxicity, and keep calcium gluconate 1 g IV at the bedside. (4) CBC with platelets, AST/ALT, LDH, creatinine, coagulation studies, urine protein quantification; continuous fetal monitoring. (5) At ≥34 weeks, preeclampsia with severe features warrants delivery once the mother is stabilized; do not delay delivery to give or complete corticosteroids. Preeclampsia itself is not an indication for cesarean; induction is reasonable absent obstetric indications.
Source ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period (2019); ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (2020)
- OB-006Multiple choiceObstetricsIntermediate
A 32-year-old multipara with asthma and preeclampsia delivers vaginally; the placenta delivers intact. The uterus is soft and boggy above the umbilicus, and blood loss reaches about 800 mL within an hour. She has received an oxytocin infusion and uterine massage; there are no genital tract lacerations, but bleeding continues 50 minutes after delivery. The most appropriate drug to add next is:
- ACarboprost tromethamine 250 μg deep IM
- BMethylergonovine 0.2 mg IM
- CRecombinant activated factor VII IV
- DOxytocin 40 units as an IV bolus
- ETranexamic acid 1 g IV over 10 minutes
Show answer
Answer E
Source ACOG Practice Bulletin No. 183: Postpartum Hemorrhage (2017); WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage (2017)
- OB-007Short answerObstetricsIntermediate
A 28-year-old primipara with no history of asthma or hypertension delivered vaginally 40 minutes ago. The placenta is out; the uterus is soft and boggy with the fundus above the umbilicus, and clots are expressed on massage. Estimated blood loss is 1300 mL and she is still actively bleeding. HR 128 bpm, BP 86/50 mm Hg, cool extremities. An oxytocin infusion is running. Describe the team's resuscitation steps (cause evaluation, drugs, transfusion strategy, and escalation when drugs fail).
Rubric
- +2Calls for help or activates the hemorrhage protocol (+1); two large-bore IVs with type and crossmatch or labs (+1)
- +2Evaluates the 4 Ts with at least two concrete examination or treatment actions
- +1Performs uterine massage or bimanual compression
- +1Adds a second uterotonic (carboprost, methylergonovine, or misoprostol) with correct dose and route, noting contraindications (carboprost in asthma, methylergonovine in hypertension) or that none apply
- +1Gives tranexamic acid 1 g IV early (stating the 3-hour window is not required)
- +2Massive transfusion with RBC:plasma about 1:1, 1:1:1 accepted (+1); fibrinogen targeting with cryoprecipitate or concentrate, or viscoelastic guidance (+1)
- +2Escalation ladder: tamponade (balloon or vacuum-induced), at least one surgical or radiologic step (compression sutures, ligation, or embolization), and hysterectomy (+2 if all three tiers are named, +1 if two)
- -3(applied once; minimum total 0) Waits for hemoglobin before transfusing, replaces blood with large-volume crystalloid or colloid, sends an unstable patient for embolization, or gives carboprost IV or methylergonovine as an IV bolus
Show answer
Reference answer Shock index about 1.5 indicates severe postpartum hemorrhage with likely ≥30% blood volume loss; visual estimates usually underestimate, so act on shock index and clinical signs and measure blood loss quantitatively from here on. (1) Call for help (senior obstetrician, anesthesia, blood bank), activate the hemorrhage protocol, assign a recorder; two large-bore IVs, oxygen, Foley catheter to keep the bladder empty; CBC, coagulation studies including fibrinogen, type and crossmatch. (2) Bimanual uterine massage or compression. (3) Evaluate the 4 Ts with concrete actions: inspect the placenta for completeness and explore the uterus for retained tissue under adequate analgesia; inspect the cervix, vagina, and perineum under good lighting, repair lacerations, look for hematoma; assess uterine contour for inversion or rupture; assess for coagulopathy. (4) Uterotonics: continue oxytocin and add a second agent — carboprost 250 μg IM every 15–90 minutes (maximum 8 doses, 2 mg; avoid in asthma; never IV), methylergonovine 0.2 mg IM every 2–4 hours (avoid in hypertension or preeclampsia; never as an IV bolus), or misoprostol 600–1000 μg orally, sublingually, or rectally. She has no contraindication to any of them; carboprost or methylergonovine is preferred for faster onset, and misoprostol is acceptable if the others are unavailable. (5) Tranexamic acid 1 g IV over 10 minutes as soon as PPH is diagnosed (effective within 3 hours of birth); repeat 1 g if bleeding continues after 30 minutes or recurs within 24 hours. (6) Activate massive transfusion: minimize crystalloid (generally ≤1.5–2 L before blood is available); give uncrossmatched group O Rh(D)-negative RBCs if needed and switch to type-specific blood as soon as available; transfuse RBCs and plasma at about 1:1 with platelets as needed; keep fibrinogen above about 200 mg/dL (cryoprecipitate or fibrinogen concentrate); use viscoelastic testing if available; keep the patient warm; correct hypocalcemia and acidosis. (7) If drugs fail: intrauterine balloon tamponade or a vacuum-induced uterine tamponade device, compression sutures (B-Lynch), uterine or hypogastric artery ligation, uterine artery embolization only if stable enough to transfer, and hysterectomy without delay. An unstable patient goes to the OR, not to interventional radiology.
Source ACOG Practice Bulletin No. 183: Postpartum Hemorrhage (2017); WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage (2017)
- OB-008Short answerObstetricsAdvanced
A 25-year-old primipara received routine oxytocin in the third stage. During controlled cord traction to deliver the placenta she develops severe lower abdominal pain and pallor; BP 70/40 mm Hg, HR 48 bpm. The fundus cannot be palpated abdominally, and a dark red mass with the placenta still attached is visible at the introitus. Give the diagnosis and emergency management.
Rubric
- +2Diagnoses acute uterine inversion (degree not required)
- +1Stops uterotonics immediately
- +2Performs immediate manual vaginal replacement (Johnson maneuver or stepwise replacement both acceptable)
- +1Explicitly addresses the attached placenta: leaves it until after replacement, or removes it only after IV access, fluids, and relaxation
- +1Uses a uterine relaxant (terbutaline, magnesium sulfate, or nitroglycerin) or halogenated general anesthesia if a constriction ring prevents replacement, with ongoing volume resuscitation
- +1Concurrent resuscitation: large-bore IV access and fluids or blood (atropine for bradycardia is acceptable but not required)
- +1After replacement keeps the hand in the uterus and gives uterotonics
- -3(applied once; minimum total 0) Explicitly recommends removing the placenta before resuscitation and relaxation, or giving, continuing, or increasing uterotonics before replacement (omission is scored only by the lost positive point)
Show answer
Reference answer Diagnosis: acute uterine inversion (complete; the degree is not required). Shock is often out of proportion to blood loss and is partly vagal, as the bradycardia here shows. (1) Call for help; two large-bore IVs, fluids, blood; atropine 1 mg IV for the bradycardia, repeated every 3–5 minutes to a maximum of 3 mg. (2) Stop oxytocin and other uterotonics and replace the uterus vaginally immediately, since the sooner, the easier: the Johnson maneuver (push the whole fundus along the vaginal axis toward the umbilicus and hold) or stepwise replacement (the part that came out last goes back first, from the cervical end, fundus last). (3) Do not remove an attached placenta before IV access, fluids, and uterine relaxation are in place; most authorities prefer leaving it attached until the uterus is replaced, although Williams also describes removing it after relaxation. (4) If a constriction ring prevents replacement, give a uterine relaxant once volume resuscitation allows — nitroglycerin 50–100 μg IV (repeatable), terbutaline 0.25 mg SC or IV, or magnesium sulfate 4–6 g IV over 15–20 minutes, watching for hypotension or tachycardia — or use general anesthesia with a halogenated agent. (5) After replacement, stop relaxants, keep the fist in the uterine cavity, start uterotonics, remove the placenta once tone returns, then withdraw the hand; manage as postpartum hemorrhage; consider prophylactic antibiotics. (6) If manual replacement fails: hydrostatic (O'Sullivan) replacement or laparotomy (Huntington or Haultain procedure).
Source Williams Obstetrics, 26th ed. (2022); ACOG Practice Bulletin No. 183: Postpartum Hemorrhage (2017)
- OB-009Multiple choiceObstetricsIntermediate
A 36-year-old G3P2 with two prior cesarean deliveries is at 33 5/7 weeks. Ultrasound and MRI show complete placenta previa with placenta percreta invading the posterior bladder wall. She has no bleeding or contractions, and mother and fetus are stable. According to the ACOG/SMFM placenta accreta spectrum consensus, the most appropriate delivery plan is:
- AExpectant management to 38–39 weeks and scheduled cesarean before labor, attempting to remove the placenta and preserve the uterus
- BImmediate cesarean; after delivering the fetus, remove the placenta manually and proceed to hysterectomy only if bleeding is heavy
- CPlanned cesarean hysterectomy at 34 0/7–35 6/7 weeks at a center with a multidisciplinary team and ample blood products, leaving the placenta in situ
- DCesarean at 36–37 weeks with routine oxytocin after delivery of the fetus to promote placental separation
- ETrial of labor under epidural analgesia to avoid another abdominal operation, without digital cervical examination
Show answer
Answer C
Source ACOG/SMFM Obstetric Care Consensus No. 7: Placenta Accreta Spectrum (2018)
- OB-010Multiple choiceObstetricsBasic
A 31-year-old multipara at 35 weeks has 2 hours of constant abdominal pain and light vaginal bleeding. The uterus is board-like and tender, without relaxation between contractions. BP 98/60 mm Hg, HR 112 bpm. The fetal heart rate has been 85–95 bpm for 6 minutes; the cervix is closed. Fibrinogen is 130 mg/dL and platelets 92,000/μL. The most appropriate management is:
- AEmergency cesarean delivery while correcting coagulopathy (cryoprecipitate or fibrinogen, plasma) and resuscitating
- BAmniotomy and oxytocin induction to achieve vaginal delivery and avoid surgical bleeding
- CTocolysis to relieve uterine hypertonus plus antenatal corticosteroids
- DCorrect fibrinogen to above 200 mg/dL and repeat coagulation studies before deciding on the mode of delivery
- EAwait spontaneous labor and vaginal delivery because the fetal prognosis is poor given the bradycardia
Show answer
Answer A
Source Williams Obstetrics, 26th ed. (2022), placental abruption; ACOG Practice Bulletin No. 183: Postpartum Hemorrhage (2017)
- OB-011Multiple choiceObstetricsAdvanced
A 33-year-old multipara at 39 weeks develops sudden coughing, agitation, and cyanosis 20 minutes after amniotomy; SpO2 is 78% and BP 62/30 mm Hg, and she then loses consciousness. After resuscitation, nonclotting blood is pouring from the vagina. Which of the following is most appropriate?
- ASend maternal blood for fetal squames or mucin and begin targeted therapy only after amniotic fluid embolism is confirmed
- BHigh-dose methylprednisolone for anaphylaxis, the core intervention that improves outcome
- CImmediate cardiopulmonary support (CPR if needed), early assessment and aggressive correction of coagulopathy (fibrinogen, platelets, plasma), and activation of massive transfusion
- DAggressive rapid fluid loading to a central venous pressure above 12 cm H2O to correct hypotension
- EUnfractionated heparin immediately because DIC is common
Show answer
Answer C
Source SMFM Clinical Guideline No. 9: Amniotic Fluid Embolism: Diagnosis and Management (2016); SMFM Special Statement: Checklist for Initial Management of Amniotic Fluid Embolism (2021)
- OB-012Short answerObstetricsAdvanced
A 30-year-old woman at 32 weeks (fundus well above the umbilicus) is admitted with pneumonia and suddenly becomes unresponsive and pulseless; the monitor shows ventricular fibrillation. Describe how resuscitation should be modified, and what should remain unchanged, compared with a nonpregnant adult, and state when and why perimortem cesarean delivery should be performed.
Rubric
- +2States what is unchanged: any two of compressions (position and depth), defibrillation energy, and drug doses (+1 each)
- +2Continuous manual left uterine displacement (lateral tilt alone earns 0)
- +1Any one of: IV access above the diaphragm, early airway management by an experienced provider, treating reversible causes (hypoxia), removing fetal monitors, activating obstetric and neonatal teams, stopping magnesium and giving calcium
- +1States that perimortem cesarean applies when the fundus is at or above the umbilicus (about ≥20 weeks)
- +1Performs it if there is no ROSC by about 4 minutes (earlier is acceptable)
- +1Prepares from arrest onset and aims for delivery within about 5 minutes (both required)
- +1Explains that the main goal is to improve maternal resuscitation
- -3(applied once; minimum total 0) Withholds or reduces defibrillation or epinephrine because of the fetus, or waits to move to the OR before cesarean
Show answer
Reference answer Unchanged: high-quality CPR (standard hand position and depth), defibrillation energy, and ACLS drug doses are the same as for a nonpregnant adult; do not reduce or delay defibrillation or epinephrine because of pregnancy. Modified: (1) continuous manual left uterine displacement to relieve aortocaval compression (manual displacement rather than lateral tilt); (2) early airway management by an experienced provider (difficult airway, aspiration risk), 100% oxygen, avoid hyperventilation; (3) IV access above the diaphragm; (4) find and treat reversible causes (here pneumonia, so hypoxia in particular); if magnesium is infusing, stop it and give IV calcium (10% calcium chloride 10 mL or 10% calcium gluconate 30 mL); (5) remove fetal monitors during resuscitation; (6) activate obstetric and neonatal teams. Perimortem cesarean delivery (resuscitative hysterotomy): indicated when the fundus is at or above the umbilicus (about ≥20 weeks). Prepare as soon as arrest is recognized and perform it at the bedside, without transfer, if there is no ROSC after about 4 minutes of resuscitation (earlier if maternal survival is clearly unlikely), aiming for delivery within about 5 minutes. The main purpose is to relieve aortocaval compression and improve maternal resuscitation; fetal salvage is secondary.
Source AHA Guidelines for CPR and ECC (2020; 2025 update); AHA Scientific Statement: Cardiac Arrest in Pregnancy (2015)
- OB-013Multiple choiceObstetricsAdvanced
A 24-year-old woman at 20 weeks has positive syphilis serology and is diagnosed with latent syphilis of unknown duration. She is prescribed benzathine penicillin G 2.4 million units IM weekly for 3 doses. Dose 1 (day 0) and dose 2 (day 7) were on time, but she returns for dose 3 on the 11th day after dose 2. She has no penicillin allergy. According to the CDC STI Treatment Guidelines (2021), the correct management is:
- AGive dose 3 today; the course is complete
- BRestart the full 3-dose weekly course
- CGive dose 3 today and add a fourth dose in 1 week
- DSwitch to ceftriaxone 1 g IM daily for 10 days
- ETwo doses are sufficient; follow RPR titers
Show answer
Answer B
Source CDC Sexually Transmitted Infections Treatment Guidelines (2021)
- OB-014Multiple choiceObstetricsIntermediate
A 30-year-old woman with a tubal ectopic pregnancy is hemodynamically stable; the adnexal mass is 2.5 cm without cardiac activity. Single-dose methotrexate 50 mg/m² IM was given on day 1 per the ACOG protocol. hCG: day 1, 1500 mIU/mL; day 4, 1720 mIU/mL; day 7, 1530 mIU/mL. Pain has not worsened and vital signs are stable. The next step is:
- AhCG fell by less than 15% from day 4 to day 7; give a second dose of methotrexate and recheck on days 11 and 14
- BhCG fell from day 4 to day 7, so treatment is working; check hCG weekly until undetectable
- ChCG rose from day 1 to day 4, indicating treatment failure; proceed to surgery
- DAdd oral mifepristone and continue observation
- ESwitch to the multidose regimen of methotrexate 1 mg/kg alternating with leucovorin for 8 days
Show answer
Answer A
Source ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy (2018)
- OB-015Multiple choiceObstetricsBasic
A 29-year-old woman at 25 weeks has no history of diabetes; her first-trimester fasting glucose was 88 mg/dL. A one-step 75-g OGTT shows fasting 95 mg/dL, 1-hour 173 mg/dL, and 2-hour 144 mg/dL. Using the one-step IADPSG criteria endorsed by the ADA Standards of Care, the correct interpretation is:
- AOnly one value is abnormal; repeat the OGTT in 1–2 weeks before making a diagnosis
- BImpaired glucose tolerance; reassess postpartum
- COvert (pregestational) diabetes, to be managed as preexisting diabetes
- DNormal; repeat testing at 32 weeks
- EGestational diabetes mellitus
Show answer
Answer E
Source ADA Standards of Care in Diabetes—2025, Section 2 (Diagnosis and Classification) and Section 15 (Management of Diabetes in Pregnancy); IADPSG Consensus Panel (2010)
- OB-016Multiple choiceObstetricsAdvanced
A 24-year-old woman with type 1 diabetes at 30 weeks has had her insulin pump fail for about 12 hours and has vomited twice. Random glucose 218 mg/dL, arterial pH 7.16, HCO3− 9 mEq/L, markedly elevated beta-hydroxybutyrate, K+ 4.6 mEq/L. The fetal tracing shows minimal variability with recurrent late decelerations. The most appropriate management is:
- AGlucose is below 250 mg/dL, so DKA is not yet diagnosed; give subcutaneous rapid-acting insulin and repeat the blood gas
- BEmergency cesarean delivery for the abnormal fetal tracing
- CIV push of sodium bicarbonate to correct the acidosis, starting insulin after the blood gas improves
- DTreat as DKA (IV fluids, IV insulin, potassium, treat the precipitant) with left lateral positioning, oxygen, and continuous fetal monitoring
- EBetamethasone for fetal lung maturity, then delivery within 24 hours
Show answer
Answer D
Source ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus (2018); ADA/EASD/JBDS/AACE/DTS Consensus Report: Hyperglycemic Crises in Adults With Diabetes (2024)
- OB-017Multiple choiceObstetricsAdvanced
A 27-year-old woman at 37 weeks is admitted in labor. Her GBS culture at 36 weeks was positive. She previously had urticaria with laryngeal edema after penicillin. GBS susceptibilities: erythromycin resistant, clindamycin inducibly resistant (positive D-test). Per ACOG Committee Opinion No. 797 (2020), intrapartum prophylaxis should be:
- ACefazolin 2 g IV, then 1 g every 8 hours until delivery
- BVancomycin 20 mg/kg IV every 8 hours (maximum 2 g per dose) until delivery
- CClindamycin 900 mg IV every 8 hours until delivery
- DErythromycin 500 mg IV every 6 hours until delivery
- ENo intrapartum prophylaxis because of allergy and resistance; evaluate the newborn after birth
Show answer
Answer B
Source ACOG Committee Opinion No. 797: Prevention of Group B Streptococcal Early-Onset Disease in Newborns (2020)
- OB-018Multiple choiceObstetricsAdvanced
A 29-year-old woman at 39 weeks with a history of VTE has been taking prophylactic enoxaparin 40 mg subcutaneously once daily; the last dose was at 21:00 last night. She is admitted in labor at 05:00, 3 cm dilated, and requests epidural analgesia. Platelets are 210,000/μL and coagulation studies are normal. Per ASRA (2018) and SOAP (2018) guidance, the correct plan is:
- APlace the epidural now; resume enoxaparin 2 hours after catheter removal
- BWait until 21:00 tonight (24 hours after the last dose); resume 24 hours after catheter removal
- CPlace the epidural after 09:00; resume enoxaparin immediately after catheter removal
- DPlace the epidural after 09:00; postpartum, resume prophylactic dosing at least 12 hours after neuraxial puncture and at least 4 hours after catheter removal
- ECheck anti-Xa activity and place the epidural if it is normal; resume 4 hours after catheter removal
Show answer
Answer D
Source ASRA: Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy, 4th ed. (2018); SOAP Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants (2018)
- OB-019Short answerObstetricsAdvanced
A 32-year-old woman at 26 weeks has had left calf pain and swelling for 3 days and today developed exertional dyspnea. HR 108 bpm, BP 118/72 mm Hg, SpO2 95% on room air; the left calf circumference is 3 cm greater than the right. Describe the diagnostic pathway and treatment plan, including drug choice and anticoagulation around delivery.
Rubric
- +2Starts with compression ultrasound; confirmed DVT allows treatment without CTPA
- +1If ultrasound is negative, proceeds to CTPA or a lung perfusion scan (chest radiograph may guide the choice)
- +1Starts anticoagulation while awaiting testing when suspicion is high
- +1Recognizes hemodynamic stability (not high-risk PE) and assesses RV function or troponin for further risk stratification
- +3Chooses weight-based therapeutic LMWH (+2) and states that warfarin and DOACs are avoided in pregnancy (+1)
- +2Holds therapeutic LMWH at least 24 hours before neuraxial anesthesia or planned delivery, or converts to UFH near term with appropriate stop times
- +1Continues anticoagulation at least 6 weeks postpartum with a total course of at least 3 months
- -3(applied once; minimum total 0) Uses warfarin or a DOAC in pregnancy, forgoes necessary imaging or anticoagulation because of radiation concerns, or permits neuraxial anesthesia within 24 hours of therapeutic LMWH
Show answer
Reference answer High suspicion of DVT with pulmonary embolism. She is normotensive, so this is not high-risk PE (high risk is defined by hemodynamic instability); assess RV function (echocardiography or CT) and troponin to separate intermediate-high from intermediate-low risk. If high-risk PE develops (hypotension), use IV unfractionated heparin with systemic thrombolysis, catheter-directed or surgical therapy, or ECMO. Diagnosis: (1) With leg symptoms, start with compression ultrasound of the leg; confirmed DVT allows VTE treatment without CTPA to prove PE. If ultrasound is negative but DVT is still suspected, consider iliac Doppler or MR venography (isolated iliac DVT is relatively common in pregnancy). (2) If ultrasound is negative and PE is still suspected: CTPA or lung perfusion (V/Q) scan (a normal chest radiograph favors perfusion scanning). D-dimer rises physiologically in pregnancy; a pregnancy-adapted YEARS algorithm or Geneva score plus D-dimer can help rule out but not confirm. (3) With high suspicion, start anticoagulation while awaiting results. Treatment: weight-based therapeutic LMWH throughout pregnancy (e.g., enoxaparin 1 mg/kg SC every 12 hours; routine anti-Xa monitoring is not required); warfarin (teratogenic, causes fetal bleeding) and DOACs are not used in pregnancy. Delivery: multidisciplinary planned delivery; instruct her to withhold LMWH at the onset of labor or rupture of membranes; hold therapeutic LMWH at least 24 hours before neuraxial anesthesia or planned delivery, or convert to unfractionated heparin near term (about 36–37 weeks) so it can be stopped closer to delivery (IV UFH 4–6 hours before with a normal aPTT; therapeutic SC UFH at least 24 hours before). Postpartum: restart once hemostasis is secure — prophylactic LMWH 4–6 hours after vaginal or 6–12 hours after cesarean delivery when no neuraxial anesthesia was used (after neuraxial, the first prophylactic dose at least 12 hours after the puncture and at least 4 hours after catheter removal), then step up; with neuraxial anesthesia, give therapeutic LMWH at least 24 hours after the puncture and at least 4 hours after catheter removal (remove the catheter before therapeutic dosing). Continue at least 6 weeks postpartum with a total course of at least 3 months. LMWH or warfarin is compatible with breastfeeding.
Source ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy (2018); ESC Guidelines for Acute Pulmonary Embolism (2019); ASH Guidelines: VTE in the Context of Pregnancy (2018); ASRA, 4th ed. (2018)
- OB-020Multiple choiceObstetricsAdvanced
A 25-year-old primigravida at 40 weeks has an intrapartum temperature of 38.9 °C (102.0 °F) and a fetal baseline of 170 bpm. Intraamniotic infection is diagnosed, and she is receiving ampicillin 2 g IV every 6 hours plus gentamicin 5 mg/kg IV once daily. Cesarean delivery is now planned for arrest of descent. Per ACOG Committee Opinion No. 712 (2017), how should the antibiotics be adjusted?
- AAdd an anaerobic agent (clindamycin 900 mg or metronidazole 500 mg IV) and give at least one additional dose after delivery
- BSwitch to cefazolin 2 g alone as routine cesarean prophylaxis
- CStop gentamicin to avoid neuromuscular blockade with anesthetic agents
- DContinue IV antibiotics for 7 days after surgery, then oral therapy to complete 14 days
- ENo change is needed; continue the current regimen until afebrile for 48 hours after surgery
Show answer
Answer A
Source ACOG Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection (2017)
- OB-021Multiple choiceObstetricsIntermediate
A 34-year-old woman with preeclampsia is on postpartum day 4 after cesarean delivery and is exclusively breastfeeding. On extended-release nifedipine 30 mg daily, BP is still 152/102 mm Hg; renal function is normal and she has no heart failure. According to NICE guideline NG133, the most appropriate drug to add is:
- AValsartan
- BEnalapril
- CMethyldopa
- DHydrochlorothiazide
- ENone until she stops breastfeeding
Show answer
Answer B
Source NICE Guideline NG133: Hypertension in Pregnancy: Diagnosis and Management (2019, updated 2023)
- OB-022Multiple choiceObstetricsIntermediate
A 26-year-old woman at 16 weeks has a reactive TP-PA and an RPR titer of 1:16; she is asymptomatic and has no record of prior syphilis testing. She reports a severe penicillin allergy (laryngeal edema after an injection). According to the CDC STI Treatment Guidelines (2021), the most appropriate treatment is:
- ADoxycycline 100 mg orally twice daily for 28 days
- BAzithromycin 2 g orally once
- CCeftriaxone 1 g IM daily for 10–14 days
- DPenicillin desensitization, then benzathine penicillin G 2.4 million units IM weekly for 3 doses
- EErythromycin 500 mg orally four times daily for 28 days, with treatment of the newborn after delivery
Show answer
Answer D
Source CDC Sexually Transmitted Infections Treatment Guidelines (2021)
- OB-023Multiple choiceObstetricsIntermediate
A 31-year-old G2P1, Rh(D)-negative on prior prenatal labs, has a spontaneous miscarriage at 8 weeks; ultrasound confirms a complete miscarriage without uterine aspiration, and bleeding has decreased. According to the ACOG Clinical Practice Update (2024), regarding Rh(D) immune globulin, the most appropriate statement is:
- AIt is reasonable to forgo Rh testing and Rh(D) immune globulin for pregnancy loss before 12 0/7 weeks
- BRh(D) immune globulin is required; give 300 μg IM within 72 hours
- CPerform a Kleihauer-Betke test first and dose by the volume of fetomaternal hemorrhage
- DRh(D) immune globulin is required; give 50 μg IM within 72 hours
- EIt is needed only after uterine aspiration; after complete spontaneous miscarriage it must be given within 7 days
Show answer
Answer A
Source ACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation (2024)
- OB-024Multiple choiceObstetricsIntermediate
A 33-year-old woman at 33 weeks has had pruritus for 3 weeks, mainly on the palms and soles, without rash. Peak total serum bile acids were 112 μmol/L, ALT 86 U/L, bilirubin normal. On ursodiol, bile acids fell to 45 μmol/L one week later. Regarding timing of delivery, according to SMFM/ACOG and RCOG guidance:
- ABile acids are now below 100 μmol/L, so expectant management to 38–39 weeks is appropriate
- BAwait spontaneous labor and consider induction after 40 weeks
- CDeliver now
- DBase timing on the response to ursodiol: once bile acids are below 40 μmol/L, delivery can be deferred to 39 weeks
- EPlan delivery at about 35–36 weeks
Show answer
Answer E
Source SMFM Consult Series #53: Intrahepatic Cholestasis of Pregnancy (2021); ACOG Committee Opinion No. 831: Medically Indicated Late-Preterm and Early-Term Deliveries (2021); RCOG Green-top Guideline No. 43 (2022)
- OB-025Multiple choiceObstetricsBasic
A 27-year-old primigravida at 35 4/7 weeks has had a week of nausea, vomiting, and fatigue and 2 days of jaundice. BP 128/80 mm Hg, urine protein negative. Labs: glucose 47 mg/dL, total bilirubin 5.7 mg/dL, ALT 312 U/L, PT 21 seconds (control 12 seconds), fibrinogen 120 mg/dL, creatinine 1.9 mg/dL, elevated ammonia, WBC 18,000/μL, platelets 142,000/μL. Ultrasound shows an echogenic liver. The most likely diagnosis is:
- AHELLP syndrome
- BAcute fatty liver of pregnancy
- CAcute viral hepatitis
- DThrombotic thrombocytopenic purpura
- EIntrahepatic cholestasis of pregnancy
Show answer
Answer B
Source Swansea criteria (Ch'ng CL et al., Gut 2002); ACG Clinical Guideline: Liver Disease and Pregnancy (2016); Williams Obstetrics, 26th ed. (2022)
- OB-026Multiple choiceObstetricsAdvanced
A 29-year-old Rh(D)-negative, unsensitized woman has an emergency cesarean at 38 weeks for placental abruption; the newborn is Rh(D) positive. The maternal rosette screen is positive, and the Kleihauer-Betke test shows 1.6% fetal red cells. Assuming a maternal blood volume of 5000 mL, how many 300-μg vials of Rh(D) immune globulin should be given, using the ACOG/AABB calculation?
- A1 vial
- B2 vials
- C3 vials
- D4 vials
- E5 vials
Show answer
Answer D
Source ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization (2017); AABB Technical Manual (fetomaternal hemorrhage quantification and RhIG dosing)
- OB-027Multiple choiceObstetricsIntermediate
A 26-year-old woman at 30 4/7 weeks has had vaginal fluid leakage for 6 hours. Speculum examination shows pooling in the posterior fornix with a positive nitrazine test. She has no contractions, no bleeding, no uterine tenderness, and no malodorous fluid; temperature 36.8 °C (98.2 °F), normal WBC, normal FHR, cephalic presentation, GBS status unknown. According to ACOG (2020), the most appropriate plan is:
- ACorticosteroids, then induction within 48 hours to avoid intraamniotic infection and abruption
- BCorticosteroids; oral amoxicillin-clavulanate for 10 days; nifedipine tocolysis until 34 weeks
- CCorticosteroids; withhold antibiotics until fever or leukocytosis develops; expectant management to 34 weeks
- DCorticosteroids; IV ampicillin plus erythromycin for 48 hours, then oral amoxicillin plus erythromycin for 5 days; magnesium if delivery before 32 weeks is anticipated; expectant management to 34 weeks
- ECorticosteroids; IV ampicillin for 48 hours; indomethacin tocolysis with expectant management to 37 weeks
Show answer
Answer D
Source ACOG Practice Bulletin No. 217: Prelabor Rupture of Membranes (2020); ACOG Committee Opinion No. 797 (2020)
- OB-028Multiple choiceObstetricsBasic
A 30-year-old multipara at 39 weeks has spontaneous rupture of membranes at 7 cm; the FHR immediately drops to 70 bpm for 3 minutes, and a pulsating cord is felt in front of the fetal head on vaginal examination. The most appropriate immediate action is:
- AReplace the cord into the uterus and recheck the FHR
- BElevate the presenting part manually (or fill the bladder with 500–750 mL via a Foley catheter), place her knee-chest or in steep Trendelenburg, and prepare for immediate cesarean
- CHave her push to expedite vaginal delivery
- DStart oxytocin to augment labor and perform forceps delivery at full dilation
- EContinue fetal monitoring for 30 minutes and perform cesarean if there is no improvement
Show answer
Answer B
Source RCOG Green-top Guideline No. 50: Umbilical Cord Prolapse (2014); Williams Obstetrics, 26th ed. (2022)
- OB-029Short answerObstetricsIntermediate
A 31-year-old multipara at 40 weeks with gestational diabetes and an estimated fetal weight of 4200 g (9 lb 4 oz) has no neuraxial analgesia. In the second stage the fetal head delivers and then retracts against the perineum (turtle sign); routine gentle axial traction on the head does not deliver the shoulders. Outline the tiered management and the maneuvers that must be avoided.
Rubric
- +1Calls for help immediately and notes the time of head delivery (both required)
- +2Uses the McRoberts maneuver as the first-line maneuver (may be combined with or simultaneous to suprapubic pressure)
- +1Adds suprapubic pressure (direction not required)
- +2If unsuccessful, uses internal maneuvers (posterior arm or rotation) or the all-fours position (order not graded)
- +1Names a last-resort maneuver (cleidotomy or deliberate clavicle fracture, humeral fracture, Zavanelli, abdominal rescue, or symphysiotomy)
- +1States that fundal pressure is prohibited
- +1States that traction beyond gentle axial traction (excessive or strong, angled beyond the fetal axis, or lateral) must be avoided; gentle axial or gentle downward traction as worded by ACOG is acceptable
- -3(applied once; minimum total 0) Recommends fundal pressure, strong or lateral head traction, episiotomy as the primary maneuver, or a last-resort maneuver before first- and second-line maneuvers
Show answer
Reference answer Diagnosis: shoulder dystocia. (1) Call for help immediately (senior obstetrician, midwife/nurse, neonatal team, anesthesia) and note the time of head delivery; ask the mother to stop pushing (not graded). (2) First line: McRoberts maneuver (hyperflex the maternal thighs onto the abdomen) plus suprapubic pressure from the side of the fetal back onto the posterior aspect of the anterior shoulder, downward and lateral, with routine axial traction; the two are often done together, and most cases resolve. (3) Second line: internal maneuvers (delivery of the posterior arm, or Rubin II or Woods screw rotation) or the all-fours (Gaskin) position, in an order chosen by operator experience and patient factors, and alternated as needed. Episiotomy does not relieve the bony impaction and is used only to gain room for internal maneuvers. (4) Last resorts: cleidotomy, the Zavanelli maneuver with cesarean, or symphysiotomy. (5) Never apply fundal pressure (worsens impaction, risks uterine rupture); avoid excessive or strong traction, traction angled beyond the fetal axis, and lateral traction on the head (gentle axial traction, described by ACOG as gentle downward traction in line with the fetal spine, is acceptable) (brachial plexus injury). (6) Afterward (not graded): examine for lacerations, anticipate postpartum hemorrhage, assess the newborn for brachial plexus injury and clavicle fracture, obtain cord gases, and document maneuvers and times.
Source RCOG Green-top Guideline No. 42: Shoulder Dystocia, 2nd ed. (2012, minor revision 2017); ACOG Practice Bulletin No. 178: Shoulder Dystocia (2017)
- OB-030Short answerObstetricsIntermediate
A 30-year-old G2P1 with blood type O Rh(D)-negative had a negative antibody screen at 28 weeks and received Rh(D) immune globulin 300 μg. At 33 weeks she is in a car crash with an abdominal impact; she has no vaginal bleeding and stable vital signs. A type and screen drawn in the ED shows a weakly positive anti-D, titer 1:2. The rest of the pregnancy is uneventful and she delivers at 39 weeks. Describe her obstetric and Rh-alloimmunization management after the trauma, and what must be done at delivery. Answer in ACOG dosing (μg); BSH IU dosing is also acceptable.
Rubric
- +3Gives anti-D within 72 hours of the trauma and states, in any wording, that the 28-week dose does not cover this event (+2 if anti-D is given without that statement)
- +2After the trauma, quantifies fetomaternal hemorrhage (Kleihauer-Betke or flow cytometry) and adds vials if it exceeds the dose's coverage
- +1States the dose-to-volume relationship (accept 300 μg ≈ 30 mL fetal whole blood ≈ 15 mL fetal red cells, or 500 IU ≈ 4 mL fetal red cells)
- +1Continuous fetal heart rate and contraction monitoring after the trauma for abruption, for at least 4–6 hours or 2–6 hours with extension if abnormal (unspecified observation earns no credit)
- +1Recognizes that a weakly positive antibody screen after recent anti-D is usually passive and does not preclude prophylaxis
- +1At delivery, types cord blood for Rh(D) and performs a postpartum fetomaternal hemorrhage screen or quantification (both required)
- +2Gives anti-D within 72 hours postpartum if the newborn is Rh(D) positive (the most recent antenatal dose, after the trauma at 33 weeks, was more than 3 weeks before delivery)
- -2(applied once) Withholds further anti-D because doses were already given, gives anti-D only if Kleihauer-Betke is positive, or withholds it because of a weakly positive screen without excluding passive anti-D
Show answer
Reference answer Abdominal blunt trauma is a sensitizing event; the 28-week prophylactic dose does not cover it. (1) Give Rh(D) immune globulin (standard 300 μg) within 72 hours of the trauma — do not wait for the Kleihauer-Betke result to decide whether to give the standard dose — and quantify fetomaternal hemorrhage (Kleihauer-Betke or flow cytometry); 300 μg covers about 30 mL of fetal whole blood (15 mL of fetal red cells), so give additional vials if the hemorrhage is larger. (2) A weakly positive antibody screen after recent anti-D is usually passive; interpret it with the injection history and titer and do not withhold prophylaxis by mistaking it for alloimmunization. (3) Continuous fetal heart rate and contraction monitoring after trauma (at least 4–6 hours; EAST recommends at least 6 hours) to detect abruption; extend monitoring or admit for contractions ≥1 per 10 minutes, uterine tenderness, bleeding, rupture of membranes, or a nonreassuring tracing. (4) At delivery, type cord blood for ABO/Rh(D) (± direct antiglobulin test); draw a maternal sample about 1 hour after delivery (not too early; BSH: 30–45 minutes to 2 hours) for a fetomaternal hemorrhage screen (rosette test), with Kleihauer-Betke or flow cytometry if positive. Her last dose was more than 3 weeks before delivery, so the postpartum dose cannot be omitted: if the newborn is Rh(D) positive, give 300 μg within 72 hours, adding vials per quantification; if 72 hours are missed, giving it within 28 days may still help. (BSH: at least 500 IU after a sensitizing event beyond 20 weeks; 500 IU covers about 4 mL of fetal red cells; 1 μg = 5 IU.)
Source ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization (2017); BSH Guideline for the Use of Anti-D Immunoglobulin for the Prevention of HDFN (2014); EAST Practice Management Guidelines: Diagnosis and Management of Injury in the Pregnant Patient (2010)